Target species Cattle, pig 4.2 Indications for use, specifying the target species Cow: - Uterine atony during the puerperal period, - Placental retention as a consequence of uterine atony - Initiation of milk ejection in stress-induced agalactia or in conditions requiring udder emptying Sow: - Uterine atony during the puerperal period - Supportive therapy of mastitis-metritis-agalactia (MMA-) syndrome - Initiation of milk ejection - Shortening of total parturition duration in sows: either after delivery of the first piglet or as a component of synchronisation of parturition in sows, which have not farrowed 24 hours after administration of an appropriate PGF2 (e.g. cloprostenol) not before day 113 of pregnancy. 4.3 Contraindications Do not administer to accelerate parturition if cervix is not opened or if there is a mechanical cause for the delayed parturition such as physical obstruction, positional and postural abnormalities, convulsive labour, threatened rupture of uterus, uterine torsion, relative foe-tal oversize or deformities of the birth canal. 4.4 Special warnings for each target species None. 4.5 Special precautions for use Special precautions for use in animals The interval between two injections should not be shorter than 24 hours. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of an accidental self-injection of the veterinary medicinal product in non-pregnant women the following effects may occur: facial flushing and warmth, lower abdominal pain. These effects usually disappear within a short span of time. Pregnant women, women post partum and breast-feeding women should not use this product, in order to avoid an accidental exposure. In case of accidental self-injection uter-ine contractions could be induced in pregnant women. 4.6 Adverse reactions (frequency and seriousness) None known. 4.7 Use during pregnancy and lactation or lay The veterinary medicinal product is indicated to induce milk ejection. See also 4.3 Contraindications. 4.8 Interaction with other medicinal products and other forms of interaction The administration of oxytocin after the administration of the veterinary medicinal product is unnecessary. Due to a possible intensification of the effect of oxytocin, undesirable uterine spasms may be induced.
Vat Rate: 20%